182 related articles for article (PubMed ID: 23267813)
21. [Impact of HLA compatibility on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia].
ZHANG Y; CHEN YK; FAN ZP; XU D; JIANG QL; SUN J; LIU QF
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):438-42. PubMed ID: 21421478
[TBL] [Abstract][Full Text] [Related]
22. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma.
Chen XY; Yan WH; Lin A; Xu HH; Zhang JG; Wang XX
Tissue Antigens; 2008 Oct; 72(4):335-41. PubMed ID: 18700878
[TBL] [Abstract][Full Text] [Related]
23. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
24. Association of
Gautam S; Kumar U; Kumar M; Kanga U; Dada R
Immunol Invest; 2020 Feb; 49(1-2):88-105. PubMed ID: 31549885
[No Abstract] [Full Text] [Related]
25. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
26. Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens.
Detrait M; Dubois V; Sobh M; Morisset S; Tedone N; Labussière H; Gillis L; Barraco F; Cannas G; Ducastelle S; Fatoum J; Thomas X; Chelgoum Y; Nicolini FE; Michallet M
Exp Hematol; 2012 Oct; 40(10):792-9. PubMed ID: 22705505
[TBL] [Abstract][Full Text] [Related]
27. Association of HLA-G 3' UTR 14-bp insertion/deletion polymorphism with hepatocellular carcinoma susceptibility in a Chinese population.
Jiang Y; Chen S; Jia S; Zhu Z; Gao X; Dong D; Gao Y
DNA Cell Biol; 2011 Dec; 30(12):1027-32. PubMed ID: 21612396
[TBL] [Abstract][Full Text] [Related]
28. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
[TBL] [Abstract][Full Text] [Related]
29. The plasma levels of soluble HLA-G molecules correlate directly with CD34+ cell concentration and HLA-G 14bp insertion/insertion polymorphism in cord blood donors.
Capittini C; Bergamaschi P; Sachetto S; Truglio M; Viola M; Marchesi A; Genovese V; Romano B; Guarene M; Poma R; Martinetti M; Tinelli C; Salvaneschi L
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s361-6. PubMed ID: 23399358
[TBL] [Abstract][Full Text] [Related]
30. New markers for predictions of acute and chronic rejection and graft outcomes in kidney transplant recipients; HLA-G gene 3'UTR 14 bp polymorphism and sHLA-G.
Darbas S; Yilmaz VT; Kocak H; Kisaoglu A; Demiryilmaz I; Aydinli B; Arslan HS; Ucar F
Gene; 2021 Jul; 790():145712. PubMed ID: 33984446
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China.
Liu QF; Xu XJ; Chen YK; Sun J; Zhang Y; Fan ZP; Xu D; Jiang QL; Wei YQ; Huang F; Feng R; Liu XL; Xu B; Meng FY
Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002
[TBL] [Abstract][Full Text] [Related]
32. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.
Danzer M; Polin H; Pröll J; Haunschmid R; Hofer K; Stabentheiner S; Hackl C; Kasparu H; König J; Hauser H; Binder M; Weiss R; Gabriel C; Krieger O
Transplantation; 2009 Aug; 88(4):528-32. PubMed ID: 19696636
[TBL] [Abstract][Full Text] [Related]
34. The impact of HLA-E polymorphisms on relapse following allogeneic hematopoietic stem cell transplantation.
Hosseini E; Schwarer AP; Jalali A; Ghasemzadeh M
Leuk Res; 2013 May; 37(5):516-9. PubMed ID: 23395341
[TBL] [Abstract][Full Text] [Related]
35. Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen.
Saure C; Schroeder T; Zohren F; Groten A; Bruns I; Czibere A; Galonska L; Kondakci M; Weigelt C; Fenk R; Germing U; Haas R; Kobbe G
Biol Blood Marrow Transplant; 2012 Mar; 18(3):466-72. PubMed ID: 21963618
[TBL] [Abstract][Full Text] [Related]
36. Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease.
Zidi I; Ben Yahia H; Bortolotti D; Mouelhi L; Laaribi AB; Ayadi S; Zidi N; Houissa F; Debbech R; Boudabous A; Najjar T; Di Luca D; Rizzo R
Int Immunol; 2015 Jun; 27(6):289-96. PubMed ID: 25577194
[TBL] [Abstract][Full Text] [Related]
37. Soluble human leukocyte antigen-G in seminal plasma is associated with HLA-G genotype: possible implications for fertility success.
Dahl M; Perin TL; Djurisic S; Rasmussen M; Ohlsson J; Buus S; Lindhard A; Hviid TV
Am J Reprod Immunol; 2014 Jul; 72(1):89-105. PubMed ID: 24735563
[TBL] [Abstract][Full Text] [Related]
38. Impact of HLA-G 14-bp polymorphism on acute rejection and cytomegalovirus infection in kidney transplant recipients from northwestern China.
Jin ZK; Xu CX; Tian PX; Xue WJ; Ding XM; Zheng J; Ding CG; Ge GQ; Mao TC; Lin Y
Transpl Immunol; 2012 Oct; 27(2-3):69-74. PubMed ID: 22750489
[TBL] [Abstract][Full Text] [Related]
39. [HLA-identical sibling allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia in first chronic phase. Analysis of 51 cases].
He Y; Feng SZ; Wang M; Wei JL; Qin TJ; Zhou Z; Zhai WJ; Qiu LG; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2005 Jul; 26(7):389-92. PubMed ID: 16251016
[TBL] [Abstract][Full Text] [Related]
40. [Clinical analysis of 104 patients with hematological malignancy after allogeneic hemotopoietic stem cell transplantation].
Chen Y; Xu Y; Zhu Y; Fu G; Liu Y; Peng J; Fu B; He Q; Wu D; Li X; Zhao X; Chen F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):859-64. PubMed ID: 21946205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]